Is AstraZeneca Set to Soar With an Advanced Breast Cancer Treatment?
During October, many Americans acknowledge breast cancer awareness month in an effort to fight this horrible disease. It is the second-leading cancer among women, behind lung cancer. About 13% of all women in the U.S. will develop the disease.
In a relentless effort to overcome this challenge, the medical community and pharmaceutical companies are heavily involved in the investigation, development, and production of treatments that could save the lives of millions. Among the companies leading the charge is AstraZeneca (NASDAQ: AZN). Its promising results in recent clinical trials might one day help the 3.8 million American women who have a history of breast cancer. It could also reward the company's investors with a 40% gain if analyst price targets are met.
Image source: Getty Images.
Source Fool.com
